Researchers at the University of Geneva have created a molecular system designed to distinguish cancer cells from healthy tissue. This system employs synthetic DNA strands to achieve targeted therapy.
The innovative approach aims to improve treatment outcomes in oncology by minimizing damage to non-cancerous cells, addressing a significant challenge in cancer treatment.
This breakthrough, published on April 1, 2026, highlights the potential for 'smart' drugs that can enhance precision in cancer therapies, paving the way for more effective treatment options.